美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Neon Therapeutics Inc.

3.07

0.0000

成交量：- -

成交额：- -

市值：8,892.76万

市盈率：-1.14

高：3.07

开：3.07

低：3.07

收：3.07

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Neon Therapeutics Inc.

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.neontherapeutics.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Neon Therapeutics, Inc.于2013年10月根据特拉华州法律注册成立，其名称为Onco3，Inc.。Neon Therapeutics，Inc.是一家临床阶段免疫肿瘤学公司，也是新抗原领域的领导者，目标疗法，致力于通过将免疫系统导向新抗原来改变癌症的治疗。基因突变是癌症的一个标志，可导致称为新抗原的特异性免疫靶标。癌细胞中新抗原的存在及其在正常细胞中的缺乏使得它们成为癌症治疗的引人注目的未开发靶标。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/NTGN/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NTGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTGN\",,,,,undefined,":{"symbol":"NTGN","market":"US","secType":"STK","nameCN":"Neon Therapeutics Inc.","latestPrice":3.07,"timestamp":1588708800000,"preClose":3.07,"halted":3,"volume":0,"delay":0,"floatShares":15196186,"shares":28966658,"eps":-2.681502,"marketStatus":"停牌","change":0,"latestTime":"05-21 17:47:19 EDT","open":3.07,"high":3.07,"low":3.07,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.681502,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1747872000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1530072000000,"exchange":"NASDAQ","adjPreClose":3.07,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTGN\",,,,,undefined,":{"symbol":"NTGN","floatShares":15196186,"roa":"-70.63%","roe":"-156.16%","lyrEps":-2.861539,"shares":28966658,"dividePrice":0,"high":3.07,"amplitude":0,"preClose":3.07,"low":3.07,"week52Low":0.88,"pbRate":"6.16","week52High":6.15,"institutionHeld":0,"latestPrice":3.07,"eps":-2.681502,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.681502,"open":3.07,"prevYearClose":1.18},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.neontherapeutics.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.1262},{"period":"3month","weight":-0.0328},{"period":"6month","weight":-0.0014},{"period":"1year","weight":0.1185},{"period":"ytd","weight":0.0116}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neon Therapeutics, Inc.于2013年10月根据特拉华州法律注册成立，其名称为Onco3，Inc.。Neon Therapeutics，Inc.是一家临床阶段免疫肿瘤学公司，也是新抗原领域的领导者，目标疗法，致力于通过将免疫系统导向新抗原来改变癌症的治疗。基因突变是癌症的一个标志，可导致称为新抗原的特异性免疫靶标。癌细胞中新抗原的存在及其在正常细胞中的缺乏使得它们成为癌症治疗的引人注目的未开发靶标。","exchange":"NASDAQ","name":"Neon Therapeutics Inc.","nameEN":"Neon Therapeutics Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NTGN\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-01","symbol":"NTGN","fiscalQuarterEnding":"2020/03","expectedEps":-0.27,"name":null,"time":"盘前","type":"earning","dateTimestamp":1588305600000,"reportTimeType":"pre","actualEps":-0.58},{"market":"US","date":"2019-11-12","symbol":"NTGN","fiscalQuarterEnding":"2019/09","expectedEps":-0.61,"name":null,"time":"","type":"earning","dateTimestamp":1573534800000,"reportTimeType":"","actualEps":-0.68},{"market":"US","date":"2019-08-06","symbol":"NTGN","fiscalQuarterEnding":"2019/06","expectedEps":-0.81,"name":null,"time":"","type":"earning","dateTimestamp":1565064000000,"reportTimeType":"","actualEps":-0.79},{"market":"US","date":"2019-05-13","symbol":"NTGN","fiscalQuarterEnding":"2019/03","expectedEps":-0.71,"name":null,"time":"","type":"earning","dateTimestamp":1557720000000,"reportTimeType":"","actualEps":-0.76},{"market":"US","date":"2019-03-11","symbol":"NTGN","fiscalQuarterEnding":"2018/12","expectedEps":-0.73,"name":null,"time":"","type":"earning","dateTimestamp":1552276800000,"reportTimeType":"","actualEps":-0.84}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NTGN\",market:\"US\",delay:false,,,undefined,":{}}}